Potent and reversible effects of ATI-2001 on atrial and atrioventricular nodal electrophysiological properties in guinea pig isolated perfused heart

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 2, 2000, Pages 779-785

  Raatikainen, M J P ^a   Morey, T E ^a   Druzgala, P ^a   Milner, P ^a   Gonzalez, M D ^a   Dennis, D M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ATI 2001; METHYL 2 [3 [4 (2 DIETHYLAMINOETHOXYL) 3,5 DIIODO]BENZOYL]BENZOFURANEACETATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; DRUG POTENCY; GUINEA PIG; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART PERFUSION; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HIS BUNDLE; NONHUMAN; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; WENCKEBACH PERIOD;

ACTION POTENTIALS; AMIODARONE; ANIMAL; ANTI-ARRHYTHMIA AGENTS; ATRIAL FUNCTION; ATRIOVENTRICULAR NODE; FEMALE; GUINEA PIGS; HEART; HEART ATRIUM; IN VITRO; MALE; NEURAL CONDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033771725     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo
2. Rhythm management in atrial fibrillation-with a primary emphasis on pharmacological therapy: Part 1
3. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The cardiac arrhythmia suppression trial (CAST.) investigators
4. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The cardiac arrhythmia suppression trial II investigators
5. Evidence-based analysis of amiodarone efficacy and safety
6. Rhythm management in atrial fibrillation-with a primary emphasis on pharmacological therapy: Part 2
7. Proarrhythmia
8. Supraventricular tachycardia
9. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias
10. Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle
11. Why does atrial fibrillation occur?
12. Atrioventricular nodal accommodation in isolated guinea pig hearts: Physiological significance and role of adenosine
13. Rhythm management in atrial fibrillation-with a primary emphasis on pharmacologic therapy: Part 3
14. Cellular electropharmacology of amiodarone
15. The effects of the new antiarrhythmic E 047/1 on postoperative ischemia-induced arrhythmias in dogs
16. Efficacy of propafenone in preventing ventricular tachycardia: Inverse correlation with rate-related prolongation of conduction time
17. Atrial fibrillation: Current knowledge and recommendations for management. Working group on arrhythmias of the European Society of Cardiology
18. AV nodal function during atrial fibrillation: The role of electrotonic modulation of propagation
19. Electrical excitability of atrioventricular nodal cells
20. Ionic basis of the differential effects of intravenous anesthetics on erythromycin-induced prolongation of ventricular repolarization in the guinea pig heart
21. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans
22. Effects of intravenous anesthetics on atrial wavelength and atrioventricular nodal conduction in guinea pig heart. Potential antidysrhythmic properties and clinical implications
23. Newer developments in the management of atrial fibrillation
24. Amiodarone: Reevaluation of an old drug
25. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association
26. Electrophysiological effects of a novel, short-acting and potent ester derivative of amiodarone, ATI-2001, in guinea pig isolated heart
27. Effects of volatile anesthetics on atrial and AV nodal electrophysiological properties in guinea pig isolated perfused heart
28. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs
29. Pharmacokinetics of amiodarone: Implications for drug therapy
30. Steady-state serum amiodarone concentrations: Relationships with antiarrhythmic efficacy and toxicity
31. Frequency-dependent electrophysiologic effects of amiodarone in humans
32. Antiarrhythmic agents for atrial fibrillation: Focus on prolonging atrial repolarization
33. Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart: Comparison with amiodarone
34. Adverse effects of low dose amiodarone: A meta-analysis
35. A general overview of amiodarone toxicity: Its prevention, detection and management
36. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats